Zobrazeno 1 - 10
of 528
pro vyhledávání: '"Nucleos(t)ide analogs"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background The best antiviral treatment for chronic hepatitis B (CHB) poses a complex challenge. The treatment effect of the combination of nucleoside analogues (NAs) and pegylated interferon alpha (PegIFN) was still in debate. Methods We st
Externí odkaz:
https://doaj.org/article/f055a74a609d4dee91b82fa7e2b7baa9
Autor:
Lina Wu, Jiadi Lai, Qiumin Luo, Yeqiong Zhang, Chaoshuang Lin, Dongying Xie, Youming Chen, Hong Deng, Zhiliang Gao, Liang Peng, Wenxiong Xu
Publikováno v:
Liver Research, Vol 8, Iss 3, Pp 179-187 (2024)
Background and aim: Few studies have reported hepatitis B surface antigen (HBsAg) kinetics after nucleos(t)ide analog (NA) discontinuation in patients with noncirrhotic chronic hepatitis B (CHB). The study specifically investigated long-term HBsAg ki
Externí odkaz:
https://doaj.org/article/415b38de27784d988b5083a1ef4ab88c
Autor:
Zhong-Bin Li, Dan-Dan Chen, Yun-Fei Jia, Qing-Juan He, Li Cui, Feng-Xia Du, Yao-Jie Kang, Xin Feng, Mengwen He, Xue-Yuan Jin, Jing Chen, Yudong Wang, Dong Ji, George Lau, Shu-Gao Wu
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundAbout 20% of on-treatment patients with chronic hepatitis B (CHB) experienced low-level viraemia (LLV), which is associated with persistent low-grade inflammation, fibrosis progression, and increased risk of hepatocellular carcinoma. We aim
Externí odkaz:
https://doaj.org/article/b040c0ad7cca4e1a80aaec9a3c154cda
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Chronic hepatitis B (CHB) is a worldwide infectious disease caused by hepatitis B virus (HBV). Optimizing antiviral treatment strategies could improve the functional cure (FC) rate of patients with CHB. This study aims to systematically
Externí odkaz:
https://doaj.org/article/ac9a0f1e46e949588bd2837654353da4
Autor:
Hao-Che Chang, Tung-Hung Su, Yu-Tsung Huang, Chun-Ming Hong, Wang-Huei Sheng, Po-Ren Hsueh, Jia-Horng Kao
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 1, Pp 55-63 (2024)
Background: Liver dysfunction is common during coronavirus disease 2019 (COVID-19), while its clinical impact and association with chronic hepatitis B (CHB) remain uncertain. We aimed to investigate liver dysfunction in COVID-19 patients and its impa
Externí odkaz:
https://doaj.org/article/1d118e0b6ce84cd1b836948ac2795ed1
Autor:
Marilena Stoian
Publikováno v:
Romanian Medical Journal, Vol 70, Iss 2, Pp 71-81 (2023)
Hepatitis B virus (HBV) infection is a global public health problem ; two billion people worldwide have evidence of past or present infection with HBV, and 296 million individuals are chronic carriers (i.e., positive for hepatitis B surface antigen [
Externí odkaz:
https://doaj.org/article/5ce91c9489e94d86baf36536f305a0d6
A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
Autor:
Guangxin Yu, Ran Chen, Sujun Zheng, Yanna Liu, Jun Zou, Zhiqiang Gu, Bei Jiang, Qi Gao, Lizhong Dai, Jie Peng, Jie Wang, Fengmin Lu
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 775-785 (2022)
Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) is a surrogate marker for reflecting the transcriptional activity of covalently closed circular DNA. However, there is still no standardized assay for the quantitative detection of serum HBV RNA in
Externí odkaz:
https://doaj.org/article/be387e0da3b248da9143dc2803e509e0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Externí odkaz:
https://doaj.org/article/66e977363d1947098f28809cdb2b6e7d
Publikováno v:
Infection and Drug Resistance, Vol Volume 15, Pp 2347-2357 (2022)
Guichan Liao, Ziying Liu, Muye Xia, Hongjie Chen, Houji Wu, Bing Li, Tao Yu, Shaohang Cai, Xiaoyong Zhang, Jie Peng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infecti
Externí odkaz:
https://doaj.org/article/0aab0e328889401b94064b6a5c37b47a